114 related articles for article (PubMed ID: 33597111)
1. Application of the Electronic Nose in Predicting Preeclampsia in High-risk Pregnancies. Pilot Study.
Rodríguez KBM; Gómez LMR; Yáñez LC; Ramírez RF; Ornelas-Rebolledo O; Borjas-García JA; Pérez-Vázquez F; Aguilar MR
Arch Med Res; 2021 Jul; 52(5):561-568. PubMed ID: 33597111
[TBL] [Abstract][Full Text] [Related]
2. Identification of volatile organic compounds in the urine of patients with cervical cancer. Test concept for timely screening.
Díaz de León-Martínez L; Flores-Ramírez R; López-Mendoza CM; Rodríguez-Aguilar M; Metha G; Zúñiga-Martínez L; Ornelas-Rebolledo O; Alcántara-Quintana LE
Clin Chim Acta; 2021 Nov; 522():132-140. PubMed ID: 34418363
[TBL] [Abstract][Full Text] [Related]
3. Application of metabolomics to preeclampsia diagnosis.
Nobakht M Gh BF
Syst Biol Reprod Med; 2018 Oct; 64(5):324-339. PubMed ID: 29965778
[TBL] [Abstract][Full Text] [Related]
4. Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant women.
Machado JSR; Machado MSR; Bertagnolli TV; Martins LAB; Freitas SF; Ovidio PP; Sandrim VC; Cardoso VC; Bettiol H; Barbieri MA; Cavalli RC
Pregnancy Hypertens; 2019 Apr; 16():105-111. PubMed ID: 31056143
[TBL] [Abstract][Full Text] [Related]
5. [Preeclampsia and thrombin generation test].
Lattová V; Procházka M; Procházková J; Ulehlová J; Slavík L; Lubušký M; Brychtová P
Ceska Gynekol; 2013 Nov; 78(5):466-72. PubMed ID: 24313434
[TBL] [Abstract][Full Text] [Related]
6. Early prediction of preeclampsia and small-for-gestational-age via multi-marker model in Chinese pregnancies: a prospective screening study.
Zhang J; Han L; Li W; Chen Q; Lei J; Long M; Yang W; Li W; Zeng L; Zeng S
BMC Pregnancy Childbirth; 2019 Aug; 19(1):304. PubMed ID: 31426761
[TBL] [Abstract][Full Text] [Related]
7. Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial.
Costantine MM; Cleary K; Hebert MF; Ahmed MS; Brown LM; Ren Z; Easterling TR; Haas DM; Haneline LS; Caritis SN; Venkataramanan R; West H; D'Alton M; Hankins G;
Am J Obstet Gynecol; 2016 Jun; 214(6):720.e1-720.e17. PubMed ID: 26723196
[TBL] [Abstract][Full Text] [Related]
8. Lipid profile and lipid oxidative modification parameters in the first trimester of high- risk pregnancies - possibilities for preeclampsia prediction.
Ardalić D; Stefanović A; Banjac G; Cabunac P; Miljković M; Mandić-Marković V; Stanimirović S; Damnjanović Pažin B; Spasić S; Spasojević-Kalimanovska V; Karadžov-Orlić N; Miković Ž
Clin Biochem; 2020 Jul; 81():34-40. PubMed ID: 32407717
[TBL] [Abstract][Full Text] [Related]
9. Predictive performance of the competing risk model in screening for preeclampsia.
Wright D; Tan MY; O'Gorman N; Poon LC; Syngelaki A; Wright A; Nicolaides KH
Am J Obstet Gynecol; 2019 Feb; 220(2):199.e1-199.e13. PubMed ID: 30447210
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum human pregnancy-specific beta-1-glycoprotein 1 levels in pregnant women with or without preeclampsia.
Temur M; Serpim G; Tuzluoğlu S; Taşgöz FN; Şahin E; Üstünyurt E
J Obstet Gynaecol; 2020 Nov; 40(8):1074-1078. PubMed ID: 31790616
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
[TBL] [Abstract][Full Text] [Related]
12. Maternal plasma fibronectin and advanced oxidative protein products for the prediction of preeclampsia in high risk pregnancies: a prospective cohort study.
Dane C; Buyukasik H; Dane B; Yayla M
Fetal Diagn Ther; 2009; 26(4):189-94. PubMed ID: 19923789
[TBL] [Abstract][Full Text] [Related]
13. Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia.
Luewan S; Teja-Intr M; Sirichotiyakul S; Tongsong T
Singapore Med J; 2018 Jan; 59(1):55-59. PubMed ID: 28451695
[TBL] [Abstract][Full Text] [Related]
14. Clinical risk assessment in early pregnancy for preeclampsia in nulliparous women: A population based cohort study.
Sandström A; Snowden JM; Höijer J; Bottai M; Wikström AK
PLoS One; 2019; 14(11):e0225716. PubMed ID: 31774875
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of CYFRA 21-1 to diagnose and predict preeclampsia: a nested case-control study.
Kuessel L; Zeisler H; Ristl R; Binder J; Pateisky P; Schmid M; Marschalek J; Perkmann T; Haslacher H; Husslein H
BMC Pregnancy Childbirth; 2016 Nov; 16(1):339. PubMed ID: 27809797
[TBL] [Abstract][Full Text] [Related]
16. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
17. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia.
Su YN; Lee CN; Cheng WF; Shau WY; Chow SN; Hsieh FJ
Obstet Gynecol; 2001 Jun; 97(6):898-904. PubMed ID: 11384693
[TBL] [Abstract][Full Text] [Related]
18. High sensitivity test for the early diagnosis of gestational hypertension and preeclampsia. II. Circadian blood pressure variability in health and hypertensive pregnant women.
Hermida RC; Ayala DE; Mojón A; Iglesias M
J Perinat Med; 1997; 25(2):153-67. PubMed ID: 9189835
[TBL] [Abstract][Full Text] [Related]
19. Prediction of preeclampsia risk in first time pregnant women: Metabolite biomarkers for a clinical test.
Kenny LC; Thomas G; Poston L; Myers JE; Simpson NAB; McCarthy FP; Brown LW; Bond AE; Tuytten R; Baker PN;
PLoS One; 2020; 15(12):e0244369. PubMed ID: 33370367
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
